A 28-year-old man with ocular myasthenia gravis (OMG) presents with persistent ptosis and diplopia despite 3 months of prednisolone therapy. He wishes to avoid long-term corticosteroids due to side effects. What is the preferred second-line agent to add for steroid-sparing effect?

See the options, answer & explanation

Sign in free to reveal the answer choices, the correct answer, the detailed explanation, and AI-powered insights for this question.